(Alliance News) - Software Circle PLC on Monday said it had entered into new loan facilities of up to GBP16.7 million with ...
(Alliance News) - The FTSE 100 closed higher on Monday as markets gave a nod of approval to Donald Trump's choice of Scott Bessent as his US Treasury pick, and hopes grew of a ceasefire between Israel ...
(Sharecast News) - London markets closed higher on Monday as investors reacted positively to geopolitical developments, including US president-elect Donald Trump's announcement of Scott Bessent as the ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...
According to the latest opinion poll by Sunday Independent/Ireland Thinks, Fine Gael support is down four percentage points to 22% since the last comparable poll earlier this month, bringing support ...
BSF Enterprise’s Lab Grown Leather has potential to be better than the real thing. Read Share Views's Articles - London South East ...
Nativo Resources PLC on Monday said its joint venture partner, Boku Resources SAC, has entered into a sales agreement with a gold ore processing plant in the Arequipa region in Peru. The Latin America ...
(Sharecast News) - London stocks were still firmer by midday on Monday as investors welcomed US President-elect Donald Trump's decision to appoint billionaire fund manager Scott Bessent as Treasury ...
(Alliance News) - Avation PLC on Monday revealed that a profitable aircraft sale has freed up cash for reinvestment into previously announced orders.
Dialight PLC on Monday provided a cautious outlook for capital expenditures, reporting an increased loss amid labour shortages and high underlying inflation. The London-based heavy industrial LED ...
(Alliance News) - Metals Exploration PLC said on Monday it expects to beat its 2024 targets for gold production and cost. The Philippines-focused gold miner said it forecasts annual gold production of ...
GSK PLC said on Monday that the US Food & Drug Administration accepted a biologics license application for its Blenrep combinations for the treatment of relapsed and refractory multiple myeloma, both ...